Voltar
Revisão Acesso aberto Produção Nacional Revisado por pares
BIBTEX RIS

Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors

2022; Multidisciplinary Digital Publishing Institute; Volume: 11; Issue: 4 Linguagem: Inglês

10.3390/cells11040618

ISSN

2073-4409

Autores

Andrígo Barboza De Nardi, Rodrigo dos Santos Horta, Carlos Eduardo Fonseca‐Alves, Felipe Noleto de Paiva, Laís Calazans Menescal Linhares, Bruna Fernanda Firmo, Felipe Augusto Ruiz Sueiro, Krishna Düro de Oliveira, Sílvia Vanessa Lourenço, Ricardo de Francisco Strefezzi, C Brunner, Marcelo Monte Mór Rangel, Paulo César Jark, Jorge Luiz Costa Castro, Rodrigo Ubukata, Karen Batschinski, Renata Afonso Sobral, Natália Oyafuso da Cruz, Adriana Tomoko Nishiya, Simone Fernandes, Simone Carvalho dos Santos Cunha, Daniel Guimarães Gerardi, Guilherme Sellera Godoy Challoub, Luiz Roberto Biondi, Renée Laufer Amorim, Paulo Ricardo de Oliveira Paes, Gleidice Eunice Lavalle, Rafael Ricardo Huppes, Fabrizio Grandi, Carmen Helena de Carvalho Vasconcellos, Denner Santos dos Anjos, Ângela Cristina Malheiros Luzo, Júlia Maria Matera, Miluše Vozdová, M.L. Dagli,

Tópico(s)

Microbial infections and disease research

Resumo

Mast cell tumors (MCTs) are hematopoietic neoplasms composed of mast cells. It is highly common in dogs and is extremely important in the veterinary oncology field. It represents the third most common tumor subtype, and is the most common malignant skin tumor in dogs, corresponding to 11% of skin cancer cases. The objective of this critical review was to present the report of the 2nd Consensus meeting on the Diagnosis, Prognosis, and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors, which was organized by the Brazilian Association of Veterinary Oncology (ABROVET) in August 2021. The most recent information on cutaneous and subcutaneous mast cell tumors in dogs is presented and discussed.

Referência(s)